BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9414013)

  • 1. Layer V neurons bear the majority of mRNAs encoding the five distinct dopamine receptor subtypes in the primate prefrontal cortex.
    Lidow MS; Wang F; Cao Y; Goldman-Rakic PS
    Synapse; 1998 Jan; 28(1):10-20. PubMed ID: 9414013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential regulation of D2 and D4 dopamine receptor mRNAs in the primate cerebral cortex vs. neostriatum: effects of chronic treatment with typical and atypical antipsychotic drugs.
    Lidow MS; Goldman-Rakic PS
    J Pharmacol Exp Ther; 1997 Nov; 283(2):939-46. PubMed ID: 9353417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypical characterization of the neurons expressing the D1 and D2 dopamine receptors in the monkey striatum.
    Aubert I; Ghorayeb I; Normand E; Bloch B
    J Comp Neurol; 2000 Feb; 418(1):22-32. PubMed ID: 10701753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of the D1 and D5 dopamine receptors in the primate prefrontal cortex by chronic treatment with antipsychotic drugs.
    Lidow MS; Elsworth JD; Goldman-Rakic PS
    J Pharmacol Exp Ther; 1997 Apr; 281(1):597-603. PubMed ID: 9103549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D2 and D4 dopamine receptor mRNA distribution in pyramidal neurons and GABAergic subpopulations in monkey prefrontal cortex: implications for schizophrenia treatment.
    de Almeida J; Mengod G
    Neuroscience; 2010 Nov; 170(4):1133-9. PubMed ID: 20727949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortical localization of dopamine D4 receptors in the rat brain--immunocytochemical study.
    Wedzony K; Chocyk A; Maćkowiak M; Fijał K; Czyrak A
    J Physiol Pharmacol; 2000 Jun; 51(2):205-21. PubMed ID: 10898094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential electrophysiological properties of dopamine D1 and D2 receptor-containing striatal medium-sized spiny neurons.
    Cepeda C; André VM; Yamazaki I; Wu N; Kleiman-Weiner M; Levine MS
    Eur J Neurosci; 2008 Feb; 27(3):671-82. PubMed ID: 18279319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Area and lamina-specific expression of GABAA receptor subunit mRNAs in monkey cerebral cortex.
    Jones EG
    Can J Physiol Pharmacol; 1997 May; 75(5):452-69. PubMed ID: 9250379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [(3)H]PNU-101958, a D(4) dopamine receptor probe, accumulates in prefrontal cortex and hippocampus of non-human primate brain.
    De La Garza R; Madras BK
    Synapse; 2000 Sep; 37(3):232-44. PubMed ID: 10881045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of D1 but not D2 dopamine receptors in striatal neurons producing neurokinin B in rats.
    Sonomura T; Nakamura K; Furuta T; Hioki H; Nishi A; Yamanaka A; Uemura M; Kaneko T
    Eur J Neurosci; 2007 Dec; 26(11):3093-103. PubMed ID: 18028111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of dopamine D2 and D4 receptor and tyrosine hydroxylase mRNA in mice prone, or resistant, to chronic high-fat diet-induced obesity.
    Huang XF; Yu Y; Zavitsanou K; Han M; Storlien L
    Brain Res Mol Brain Res; 2005 Apr; 135(1-2):150-61. PubMed ID: 15857678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of the expression of dopamine D1 and D2 receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex.
    Santana N; Mengod G; Artigas F
    Cereb Cortex; 2009 Apr; 19(4):849-60. PubMed ID: 18689859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET.
    Okubo Y; Suhara T; Suzuki K; Kobayashi K; Inoue O; Terasaki O; Someya Y; Sassa T; Sudo Y; Matsushima E; Iyo M; Tateno Y; Toru M
    Nature; 1997 Feb; 385(6617):634-6. PubMed ID: 9024661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcellular localization of the dopamine D2 receptor and coexistence with the calcium-binding protein neuronal calcium sensor-1 in the primate prefrontal cortex.
    Negyessy L; Goldman-Rakic PS
    J Comp Neurol; 2005 Aug; 488(4):464-75. PubMed ID: 15973684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated administration of a dopamine D1 receptor agonist reverses the increased proportions of striatal dopamine D1High and D2High receptors in methamphetamine-sensitized rats.
    Shuto T; Seeman P; Kuroiwa M; Nishi A
    Eur J Neurosci; 2008 May; 27(10):2551-7. PubMed ID: 18489579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneous distribution of D1, D2 and D5 receptor mRNAs in monkey striatum.
    Rappaport MS; Sealfon SC; Prikhozhan A; Huntley GW; Morrison JH
    Brain Res; 1993 Jul; 616(1-2):242-50. PubMed ID: 8358616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum.
    Bruins Slot LA; Lestienne F; Grevoz-Barret C; Newman-Tancredi A; Cussac D
    Eur J Pharmacol; 2009 Oct; 620(1-3):27-35. PubMed ID: 19695244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial bilateral mesencephalic lesions affect D1 but not D2 binding in both the striatum and cortex.
    Pioli E; Sohr R; Meissner W; Barthe N; Gross CE; Bezard E; Bioulac BH
    Neurochem Int; 2004 Dec; 45(7):995-1004. PubMed ID: 15337298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine D3 receptor antisense administration reduces basal c-fos and NGFI-B mRNA levels in the rat forebrain.
    Tremblay M; Rouillard C; Lévesque D
    Synapse; 1999 Apr; 32(1):51-7. PubMed ID: 10188638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased prefrontal D2 protein in Tourette syndrome: a postmortem analysis of frontal cortex and striatum.
    Minzer K; Lee O; Hong JJ; Singer HS
    J Neurol Sci; 2004 Apr; 219(1-2):55-61. PubMed ID: 15050438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.